Deregulation of PERK in the autoimmune disease pemphigus vulgaris occurs via IgG-independent mechanisms

British Journal of Dermatology

Volumn 164, Issue 2, 2011, Pages 336-343

  Lanza, A ^a   Lanza, M ^a   Santoro, R ^a   Soro, V ^b   Prime, S S ^b   Cirillo, Nicola ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INITIATION FACTOR 2ALPHA; PROTEIN KINASE; PROTEIN KINASE R LIKE ENDOPLASMIC RETICULUM KINASE; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CELL CYCLE; CELL METABOLISM; CELL VIABILITY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; KERATINOCYTE; PATHOGENESIS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 79551488771     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10084.x     Document Type: Article

References (44)

1. Cirillo N, Lanza A, Gombos F, (eds). Pathophysiology of the Desmosome. Trivandrum, KL, India: Research Signpost, 2009.
2. Bystryn JC, Rudolph JL,. Pemphigus. Lancet 2005; 366: 61-73.
3. Langan SM, Smeeth L, Hubbard R, et al. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ 2008; 337: a180.
4. Chams-Davatchi C, Esmaili N, Daneshpazhooh M, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol 2007; 57: 622-8.
5. Carson PJ, Hameed A, Ahmed AR,. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 1996; 34: 645-52.
6. Herbst A, Bystryn JC,. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000; 42: 422-7.
7. Mourellou O, Chaidemenos GC, Koussidou T, Kapetis E,. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period. Br J Dermatol 1995; 133: 83-7.
8. Waschke J,. The desmosome and pemphigus. Histochem Cell Biol 2008; 130: 21-54.
9. Yamamoto Y, Aoyama Y, Shu E, et al. Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity. J Biol Chem 2007; 282: 17866-76.
10. Cirillo N, Femiano F, Gombos F, Lanza A,. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett 2006; 580: 3276-81.
11. Cirillo N, Lanza M, De Rosa A, et al. At least three phosphorylation events induced by pemphigus vulgaris sera are pathogenically involved in keratinocyte acantholysis. Int J Immunopathol Pharmacol 2008; 21: 189-95.
12. Nguyen VT, Arredondo J, Chernyavsky AI, et al. Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. J Biol Chem 2004; 279: 2135-46.
13. Jolly PS, Berkowitz P, Bektas M, et al. p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem 2010; 285: 8936-41.
14. Chernyavsky AI, Arredondo J, Kitajima Y, et al. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem 2007; 282: 13804-12.
15. Cirillo N, Lanza M, Femiano F, et al. If pemphigus vulgaris IgG are the cause of acantholysis, new IgG-independent mechanisms are the concause. J Cell Physiol 2007; 212: 563-7.
16. Grando SA, Bystryn JC, Chernyavsky AI, et al. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis. Exp Dermatol 2009; 18: 764-70.
17. Chernyavsky AI, Arredondo J, Piser T, et al. Differential coupling of M1 muscarinic and alpha7 nicotinic receptors to inhibition of pemphigus acantholysis. J Biol Chem 2008; 283: 3401-8.
18. Lanza A, Cirillo N, Rossiello R, et al. Evidence of key role of Cdk2 overexpression in pemphigus vulgaris. J Biol Chem 2008; 283: 8736-45.
19. Berkowitz P, Hu P, Warren S, et al. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci USA 2006; 103: 12855-60.
20. Boukamp P, Petrussevska RT, Breitkreutz D, et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-71.
21. Calautti E, Cabodi S, Stein PL, et al. Tyrosine phosphorylation and Src-family kinases control keratinocyte cell-cell adhesion. J Cell Biol 1998; 141: 1449-65.
22. Cirillo N, Lanza A, Prime SS,. Induction of hyper-adhesion attenuates autoimmune-induced keratinocyte cell-cell detachment and processing of adhesion molecules via mechanisms that involve PKC. Exp Cell Res 2010; 316: 580-92.
23. Puviani M, Marconi A, Cozzani E, Pincelli C,. Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. J Invest Dermatol 2003; 120: 164-7.
24. Ameglio F, D'Auria L, Cordiali-Fei P, et al. Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients with pemphigus vulgaris relationships with peripheral blood neutrophil counts, disease severity and duration and patients' age. J Biol Regul Homeost Agents 1999; 13: 220-4.
25. Bhol KC, Desai A, Kumari S, et al. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. Clin Immunol 2001; 100: 172-80.
26. Narbutt J, Lukamowicz J, Bogaczewicz J, et al. Serum concentration of interleukin-6 is increased both in active and remission stages of pemphigus vulgaris. Mediators Inflamm 2008; 2008: 875394.
27. Siebra MX, Santos MA, Almeida TL, et al. Evidence for the participation of nitric oxide in pemphigus. Braz J Med Biol Res 2006; 39: 671-5.
28. Marquina M, Espana A, Fernandez-Galar M, Lopez-Zabalza MJ,. The role of nitric oxide synthases in pemphigus vulgaris in a mouse model. Br J Dermatol 2008; 159: 68-76.
29. Grando SA,. Decompensation in proteinase-inhibitor system and application of proteinase inhibitors in pemphigus and pemphigoid. J Dermatol Sci 1992; 4: 95-7.
30. Cirillo N, Lanza M, Rossiello L, et al. Defining the involvement of proteinases in pemphigus vulgaris: evidence of matrix metalloproteinase-9 overexpression in experimental models of disease. J Cell Physiol 2007; 212: 36-41.
31. Schröder M, Kaufman RJ,. The mammalian unfolded protein response. Annu Rev Biochem 2005; 74: 739-89.
32. Boyce M, Yuan J,. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 2006; 13: 363-73.
33. Chami M, Oulès B, Szabadkai G, et al. Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress. Mol Cell 2008; 32: 641-51.
34. Bourougaa K, Naski N, Boularan C, et al. Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47. Mol Cell 2010; 38: 78-88.
35. Guan D, Xu Y, Yang M, et al. N-acetyl cysteine and penicillamine induce apoptosis via the ER stress response-signaling pathway. Mol Carcinog 2010; 49: 68-74.
36. Kim KW, Moretti L, Mitchell LR, et al. Endoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2alpha in caspase-3/7-deficient cells. Oncogene 2010; 29: 3241-51.
37. Park MA, Zhang G, Martin AP, et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther 2008; 7: 1648-62.
38. Marchenko S, Chernyavsky AI, Arredondo J, et al. Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. J Biol Chem 2010; 285: 3695-704.
39. Tonnesen MF, Grunnet LG, Friberg J, et al. Inhibition of nuclear factor-kappaB or Bax prevents endoplasmic reticulum stress-but not nitric oxide-mediated apoptosis in INS-1E cells. Endocrinology 2009; 150: 4094-103.
40. Okunade GW, Miller ML, Azhar M, et al. Loss of the Atp2c1 secretory pathway Ca(2+)-ATPase (SPCA1) in mice causes Golgi stress, apoptosis, and midgestational death in homozygous embryos and squamous cell tumors in adult heterozygotes. J Biol Chem 2007; 282: 26517-27.
41. Pani B, Singh BB,. Darier's disease: a calcium-signaling perspective. Cell Mol Life Sci 2008; 65: 205-11.
42. Missiaen L, Raeymaekers L, Dode L, et al. SPCA1 pumps and Hailey-Hailey disease. Biochem Biophys Res Commun 2004; 322: 1204-13.
43. Cirillo N, Prime SS,. Desmosomal interactome in keratinocytes: a systems biology approach leading to an understanding of the pathogenesis of skin disease. Cell Mol Life Sci 2009; 66: 3517-33.
44. Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science 2002; 298: 1912-34.